SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-10-017110
Filing Date
2010-03-31
Accepted
2010-03-31 12:25:43
Documents
11
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 v179142_10k.htm 10-K 2305117
2 GRAPHIC chart.jpg GRAPHIC 90945
3 v179142_ex4-9.htm EX-4.9 117911
4 v179142_ex4-10.htm EX-4.10 113927
5 v179142_ex10-35.htm EX-10.35 124582
6 v179142_ex10-36.htm EX-10.36 178135
7 v179142_ex10-37.htm EX-10.37 136831
8 v179142_ex23-1.htm EX-23.1 3907
9 v179142_ex31-1.htm EX-31.1 14579
10 v179142_ex31-2.htm EX-31.2 13134
11 v179142_ex32-1.htm EX-32.1 6496
  Complete submission text file 0001144204-10-017110.txt   3141705
Mailing Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019
Business Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019 (212) 582-3950
MANHATTAN PHARMACEUTICALS INC (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32639 | Film No.: 10717369
SIC: 2834 Pharmaceutical Preparations